Results 231 to 240 of about 12,789,497 (387)

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

open access: yesEBioMedicine, 2019
V. Aho   +6 more
semanticscholar   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

open access: yesMolecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin   +10 more
wiley   +1 more source

Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression. [PDF]

open access: yesPediatr Rheumatol Online J
Shi J   +9 more
europepmc   +1 more source

Molecular Follow-Up of Disease Progression and Interferon Therapy in Chronic Myelocytic Leukemia [PDF]

open access: bronze, 1997
Dina Ben‐Yehuda   +10 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Case report of an aggressive cardiac myxofibrosarcoma with rapid disease progression. [PDF]

open access: yesEur Heart J Case Rep
Nakamura K   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy